Bristol-Myers Squibb Co (BMY)

58.88 +0.48 (+0.81%) USD  |  NYSE  |  Nov 14, 12:14
More

Bristol-Myers Squibb Research and Development Expense (Quarterly): 2.374B for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1994. Upgrade now.
Date Value
September 30, 2024 2.374B
June 30, 2024 2.899B
March 31, 2024 2.695B
December 31, 2023 2.478B
September 30, 2023 2.242B
June 30, 2023 2.258B
March 31, 2023 2.321B
December 31, 2022 2.51B
September 30, 2022 2.418B
June 30, 2022 2.321B
March 31, 2022 2.26B
December 31, 2021 2.518B
September 30, 2021 2.98B
June 30, 2021 2.478B
March 31, 2021 2.219B
December 31, 2020 3.75B
September 30, 2020 2.499B
June 30, 2020 2.522B
March 31, 2020 2.372B
December 31, 2019 2.097B
September 30, 2019 1.378B
June 30, 2019 1.325B
March 31, 2019 1.348B
December 31, 2018 1.367B
September 30, 2018 1.28B
Date Value
June 30, 2018 2.435B
March 31, 2018 1.25B
December 31, 2017 1.925B
September 30, 2017 1.561B
June 30, 2017 1.679B
March 31, 2017 1.303B
December 31, 2016 1.472B
September 30, 2016 1.138B
June 30, 2016 1.266B
March 31, 2016 1.136B
December 31, 2015 1.916B
September 30, 2015 1.132B
June 30, 2015 1.856B
March 31, 2015 1.016B
December 31, 2014 1.189B
September 30, 2014 983.00M
June 30, 2014 1.416B
March 31, 2014 946.00M
December 31, 2013 957.00M
September 30, 2013 893.00M
June 30, 2013 951.00M
March 31, 2013 930.00M
December 31, 2012 1.082B
September 30, 2012 951.00M
June 30, 2012 962.00M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

2.097B
Minimum
Dec 2019
3.75B
Maximum
Dec 2020
2.511B
Average
2.448B
Median

Research and Development Expense (Quarterly) Benchmarks

Amgen Inc 1.45B
Johnson & Johnson 4.952B
Eli Lilly and Co 2.734B
Merck & Co Inc 5.862B
Pfizer Inc 2.598B